RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

www.rheumatic.theclinics.com

Consulting Editor

MICHAEL H. WEISMAN

February 2017 • Volume 43 • Number 1

Only gold members can continue reading. Log In or Register to continue

Share this:

• Click to share on Twitter (Opens in new window)
• Click to share on Facebook (Opens in new window)

Related

Related posts:

Infection and Malignancy in Rheumatic Diseases Infection and Malignancy in Rheumatic Diseases Vaccines and Disease-Modifying Antirheumatic Drugs Immune-Related Adverse Effects of Cancer Immunotherapy— Implications for Rheumatology Malignancy and Janus Kinase Inhibition The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era

Stay updated, free articles. Join our Telegram channel

Join

Full access? Get Clinical Tree